Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000728957 | SCV000856586 | pathogenic | not provided | 2017-09-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003512073 | SCV004298942 | pathogenic | Duchenne muscular dystrophy | 2023-03-02 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. Studies have shown that disruption of this splice site results in skipping of exon 4, but is expected to preserve the integrity of the reading-frame (PMID: 32504006). ClinVar contains an entry for this variant (Variation ID: 593815). Disruption of this splice site has been observed in individual(s) with dystrophinopathy (PMID: 25972034, 28859693, 32504006). This variant is not present in population databases (gnomAD no frequency). This sequence change affects a donor splice site in intron 4 of the DMD gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. |